Use of 3D Bioprinting for Development of Toxicity Prediction Models

12:32 EDT 27 Apr 2019 | Leaders in Pharmaceutical Business Intelligence

Use of 3D Bioprinting for Development of Toxicity Prediction Models Curator: Stephen J. Williams, PhD SOT FDA Colloquium on 3D Bioprinted Tissue Models: Tuesday, April 9, 2019 The Society of Toxicology (SOT) and the U.S. Food and Drug Administration (FDA) will hold a workshop on “Alternative Methods for Predictive Safety Testing: 3D Bioprinted Tissue Models” […]

Original Article: Use of 3D Bioprinting for Development of Toxicity Prediction Models

More From BioPortfolio on "Use of 3D Bioprinting for Development of Toxicity Prediction Models"